| Juliet K Markham, MD | |
|
27swfrazer Ave, Pendleton, OR 97801-2147 | |
| (541) 278-3377 | |
| (541) 278-2434 |
| Full Name | Juliet K Markham |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 27swfrazer Ave, Pendleton, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578564415 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 28773 (Tennessee) | Secondary |
| 207V00000X | Obstetrics & Gynecology | MD26356 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Juliet K Markham, MD Po Box 1438, Pendleton, OR 97801-0350 Ph: (541) 278-3377 | Juliet K Markham, MD 27swfrazer Ave, Pendleton, OR 97801-2147 Ph: (541) 278-3377 |
News Archive
Screening to detect medical conditions has become standard practice for many diseases, but insufficient attention has been paid to the potential for harm, according to research conducted at the University of North Carolina.
Most Americans have never heard of Dr. Richard Whitley, an expert in pediatric infectious diseases at the University of Alabama-Birmingham.
A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine 's Advance Online Publication March 1.
Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™, its nanoparticle reformulation of paclitaxel, in the August issue of the Journal of Nanoscience and Nanotechnology. The publication highlights data demonstrating improved safety and efficacy of EmPAC™ versus Taxol®, the generic formulation of paclitaxel and one of the most widely prescribed chemotherapies. EmPAC™ is a nanoemulsion formulation of Paclitaxel and is the lead product candidate of Cornerstone's proprietary Emulsiphan™ cancer selective delivery nanotechnology platform. Taxol®, an injectable formulation of Paclitaxel, is currently used to treat a variety of cancers, including ovarian carcinomas, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
The U.S. Food and Drug Administration (FDA) has sent a warning letter to Procter & Gamble for making unlawful claims about its Vicks Early Defense Foaming Hand Sanitizer (Early Defense) product.
› Verified 1 days ago
James Denton Ward, D.O. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3001 St Anthony Way Ste 205, Pendleton, OR 97801 Phone: 541-966-0535 Fax: 541-278-4584 | |
Dr. Carlotto Anzette Fisher, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2801 St Anthony Way, Pendleton, OR 97801 Phone: 541-276-5121 | |
Dr. Joseph J Wujek, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 46314 Timine Way, Pendleton, OR 97801 Phone: 541-966-9830 Fax: 541-240-8751 | |
Patricia J Winn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3001 St Anthony Way Ste 135, Pendleton, OR 97801 Phone: 541-278-1348 Fax: 541-278-2164 |